These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9851582)

  • 1. Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo.
    Ferger B; Spratt C; Teismann P; Seitz G; Kuschinsky K
    Eur J Pharmacol; 1998 Nov; 360(2-3):155-63. PubMed ID: 9851582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
    Ferger B; Spratt C; Earl CD; Teismann P; Oertel WH; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):351-9. PubMed ID: 9774223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping.
    Ferger B; Teismann P; Earl CD; Kuschinsky K; Oertel WH
    Pharmacol Biochem Behav; 2000 Mar; 65(3):425-31. PubMed ID: 10683482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
    Mohanakumar KP; Muralikrishnan D; Thomas B
    Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 1997; 104(6-7):579-92. PubMed ID: 9444559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Thomas B; Muralikrishnan D; Mohanakumar KP
    Brain Res; 2000 Jan; 852(1):221-4. PubMed ID: 10661517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of 3-O-demethylswertipunicoside against MPTP-induced Parkinson's disease in vivo and its antioxidant properties in vitro.
    Zhou JJ; Zhai SY; Zhang HN; Wang YH; Pu XP
    Brain Res; 2015 Oct; 1624():78-85. PubMed ID: 26210618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.
    Youdim MB; Grünblatt E; Mandel S
    J Neural Transm (Vienna); 2007 Feb; 114(2):205-9. PubMed ID: 16736232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in mice.
    Knaryan VH; Samantaray S; Galoyan AA; Mohanakumar KP
    Neurosci Lett; 2005 Mar; 375(3):187-91. PubMed ID: 15694258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Muralikrishnan D; Mohanakumar KP
    FASEB J; 1998 Jul; 12(10):905-12. PubMed ID: 9657530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity.
    Schulz JB; Henshaw DR; Matthews RT; Beal MF
    Exp Neurol; 1995 Apr; 132(2):279-83. PubMed ID: 7789466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
    Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
    Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
    Pennathur S; Jackson-Lewis V; Przedborski S; Heinecke JW
    J Biol Chem; 1999 Dec; 274(49):34621-8. PubMed ID: 10574926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.